vs
Biofrontera Inc.（BFRI）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是Biofrontera Inc.的1.9倍（$32.3M vs $17.1M），Biofrontera Inc.净利率更高（33.0% vs 31.5%，领先1.5%），Biofrontera Inc.同比增速更快（36.2% vs 12.6%），RBB Bancorp自由现金流更多（$42.6M vs $-2.4M），过去两年Biofrontera Inc.的营收复合增速更高（47.0% vs 7.0%）
Biofrontera Inc.是一家专注于皮肤病治疗领域的特种生物制药企业，主要研发和商业化处方类皮肤科药物，核心产品线针对光化性角化病等常见皮肤病症，主要市场覆盖美国及欧盟地区，服务皮肤科医护人员与患者。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
BFRI vs RBB — 直观对比
营收规模更大
RBB
是对方的1.9倍
$17.1M
营收增速更快
BFRI
高出23.6%
12.6%
净利率更高
BFRI
高出1.5%
31.5%
自由现金流更多
RBB
多$45.0M
$-2.4M
两年增速更快
BFRI
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $17.1M | $32.3M |
| 净利润 | $5.6M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | 26.6% | 39.5% |
| 净利率 | 33.0% | 31.5% |
| 营收同比 | 36.2% | 12.6% |
| 净利润同比 | 504.0% | 132.1% |
| 每股收益（稀释后） | $0.62 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BFRIRBB
| Q4 25 | $17.1M | $32.3M | ||
| Q3 25 | $7.0M | $32.6M | ||
| Q2 25 | $9.0M | $35.8M | ||
| Q1 25 | $8.6M | $28.5M | ||
| Q4 24 | $12.6M | $28.7M | ||
| Q3 24 | $9.0M | $30.3M | ||
| Q2 24 | $7.8M | $27.5M | ||
| Q1 24 | $7.9M | $28.2M |
净利润BFRIRBB
| Q4 25 | $5.6M | $10.2M | ||
| Q3 25 | $-6.6M | $10.1M | ||
| Q2 25 | $-5.3M | $9.3M | ||
| Q1 25 | $-4.2M | $2.3M | ||
| Q4 24 | $-1.4M | $4.4M | ||
| Q3 24 | $-5.7M | $7.0M | ||
| Q2 24 | $-257.0K | $7.2M | ||
| Q1 24 | $-10.4M | $8.0M |
营业利润率BFRIRBB
| Q4 25 | 26.6% | 39.5% | ||
| Q3 25 | -89.8% | 40.7% | ||
| Q2 25 | -56.2% | 36.1% | ||
| Q1 25 | -52.9% | 11.2% | ||
| Q4 24 | -13.6% | 17.6% | ||
| Q3 24 | -55.0% | 31.6% | ||
| Q2 24 | -64.7% | 35.6% | ||
| Q1 24 | -69.1% | 39.9% |
净利率BFRIRBB
| Q4 25 | 33.0% | 31.5% | ||
| Q3 25 | -95.1% | 31.2% | ||
| Q2 25 | -59.0% | 26.1% | ||
| Q1 25 | -48.9% | 8.0% | ||
| Q4 24 | -11.1% | 15.3% | ||
| Q3 24 | -62.9% | 23.1% | ||
| Q2 24 | -3.3% | 26.4% | ||
| Q1 24 | -131.9% | 28.4% |
每股收益（稀释后）BFRIRBB
| Q4 25 | $0.62 | $0.59 | ||
| Q3 25 | $-0.62 | $0.59 | ||
| Q2 25 | $-0.57 | $0.52 | ||
| Q1 25 | $-0.47 | $0.13 | ||
| Q4 24 | $0.69 | $0.26 | ||
| Q3 24 | $-0.98 | $0.39 | ||
| Q2 24 | $-0.05 | $0.39 | ||
| Q1 24 | $-2.88 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $10.5M | $523.4M |
| 总资产 | $28.6M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资BFRIRBB
| Q4 25 | $6.4M | $212.3M | ||
| Q3 25 | $3.4M | $234.9M | ||
| Q2 25 | $7.2M | $191.9M | ||
| Q1 25 | $1.8M | $238.8M | ||
| Q4 24 | $5.9M | $257.7M | ||
| Q3 24 | $2.9M | $349.4M | ||
| Q2 24 | $4.4M | $252.8M | ||
| Q1 24 | $3.8M | — |
总债务BFRIRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益BFRIRBB
| Q4 25 | $10.5M | $523.4M | ||
| Q3 25 | $-2.6M | $514.3M | ||
| Q2 25 | $-4.7M | $517.7M | ||
| Q1 25 | $500.0K | $510.3M | ||
| Q4 24 | $4.4M | $507.9M | ||
| Q3 24 | $5.5M | $509.7M | ||
| Q2 24 | $10.9M | $511.3M | ||
| Q1 24 | $-5.4M | $514.0M |
总资产BFRIRBB
| Q4 25 | $28.6M | $4.2B | ||
| Q3 25 | $15.4M | $4.2B | ||
| Q2 25 | $20.1M | $4.1B | ||
| Q1 25 | $16.6M | $4.0B | ||
| Q4 24 | $22.1M | $4.0B | ||
| Q3 24 | $18.5M | $4.0B | ||
| Q2 24 | $21.6M | $3.9B | ||
| Q1 24 | $24.6M | $3.9B |
负债/权益比BFRIRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.4M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | $42.6M |
| 自由现金流率自由现金流/营收 | -13.9% | 131.8% |
| 资本支出强度资本支出/营收 | 0.0% | 2.5% |
| 现金转化率经营现金流/净利润 | -0.42× | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-13.4M | $73.5M |
8季度趋势，按日历期对齐
经营现金流BFRIRBB
| Q4 25 | $-2.4M | $43.4M | ||
| Q3 25 | $-3.8M | $2.1M | ||
| Q2 25 | $-3.0M | $21.7M | ||
| Q1 25 | $-4.1M | $7.8M | ||
| Q4 24 | $-1.0M | $58.5M | ||
| Q3 24 | $-1.2M | $24.5M | ||
| Q2 24 | $-4.7M | $11.7M | ||
| Q1 24 | $-3.3M | $4.8M |
自由现金流BFRIRBB
| Q4 25 | $-2.4M | $42.6M | ||
| Q3 25 | $-3.8M | $1.8M | ||
| Q2 25 | $-3.0M | $21.6M | ||
| Q1 25 | $-4.1M | $7.6M | ||
| Q4 24 | $-1.0M | $57.7M | ||
| Q3 24 | — | $24.2M | ||
| Q2 24 | $-4.8M | $11.5M | ||
| Q1 24 | $-3.4M | $4.7M |
自由现金流率BFRIRBB
| Q4 25 | -13.9% | 131.8% | ||
| Q3 25 | -54.7% | 5.4% | ||
| Q2 25 | -33.7% | 60.2% | ||
| Q1 25 | -48.0% | 26.7% | ||
| Q4 24 | -8.1% | 201.0% | ||
| Q3 24 | — | 80.0% | ||
| Q2 24 | -60.8% | 42.0% | ||
| Q1 24 | -42.7% | 16.6% |
资本支出强度BFRIRBB
| Q4 25 | 0.0% | 2.5% | ||
| Q3 25 | 0.0% | 1.1% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.0% | 2.7% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.6% | 0.5% | ||
| Q1 24 | 0.7% | 0.5% |
现金转化率BFRIRBB
| Q4 25 | -0.42× | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
